000788.SZ
Get informed when a big investor buys or sells
+ FollowUndervalued by 16.2% based on the discounted cash flow analysis.
| Market cap | $3.38 Billion |
|---|---|
| Enterprise Value | $2.70 Billion |
| Dividend Yield | $0.20 (3.49%) |
| Earnings per Share | $0.14 |
| Beta | 0.15 |
| Outstanding Shares | 595,987,425 |
| P/E Ratio | 88.32 |
|---|---|
| PEG | -185.8 |
| Price to Sales | 5.86 |
| Price to Book Ratio | 2.93 |
| Enterprise Value to Revenue | 2.77 |
| Enterprise Value to EBIT | 80.22 |
| Enterprise Value to Net Income | 70 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.09 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
Operating within China, PKU HealthCare Corp.,Ltd. is a pharmaceutical company that specializes in the research, development, manufacturing, and distribution of medicinal products. Its extensive portfolio encompasses a broad spectrum of t...